SCHEMBL18554286

SCHEMBL18554286

O=C(CC[C@@H](Cc1ccc(-c2ccccc2)cc1)N(Cc1ccccc1)Cc1ccccc1)N1CCCC1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.57
NPC1 O15118 3/20 0.49
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 3/20 0.44
LMNA P02545 1/20 0.44
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.42
KMT2A Q03164 1/20 0.42
HRH3 Q9Y5N1 3/20 0.42
DPP7 Q9UHL4 1/20 0.42
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18554287 1.00 NAAA (0.57) NAAANPC1TDP1ALDH1A1LMNA
SCHEMBL18554201 0.82 FFAR1 (0.53) LMNA
SCHEMBL18554199 0.82 FFAR1 (0.53) LMNA
Hydrochloric Acid SCHEMBL18554214 0.81 FFAR1 (0.51) ALDH1A1MAPT
Hydrochloric Acid SCHEMBL18554213 0.81 FFAR1 (0.51) ALDH1A1MAPT
SCHEMBL18554136 0.81 HRH3 (0.46) NPC1RAB9AMEN1KMT2AHRH3
SCHEMBL18554135 0.81 HRH3 (0.46) NPC1RAB9AMEN1KMT2AHRH3
SCHEMBL18576667 0.81 HRH3 (0.46) NPC1RAB9AMEN1KMT2AHRH3
SCHEMBL18576607 0.81 HRH3 (0.46) NPC1RAB9AMEN1KMT2AHRH3
SCHEMBL18554139 0.81 HRH3 (0.46) NPC1RAB9AMEN1KMT2AHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017033128-A1 BIPHENYL-SUBSTITUED 4-AMINO-BUTYRIC ACID DERIVATIVES AND THEIR USE IN THE SYNTHESIS OF NEP INHIBITORS NOVARTIS AG (CH) 2017-03-02 WO disclosed
WO-2017033128-A1 BIPHENYL-SUBSTITUED 4-AMINO-BUTYRIC ACID DERIVATIVES AND THEIR USE IN THE SYNTHESIS OF NEP INHIBITORS NOVARTIS AG (CH) 2017-03-02 WO disclosed